Hormone Replacement Therapy and Cardiovascular Disease: The Current Status of Research and Practice

This is a high-level, cutting-edge clinical reference by world-class specialists on the efficacy of hormone replacement therapy for the primary prevention of cardiovascular risk in postmenopausal women. It contains 23 chapters on the relationships between hormone replacement therapy and the lipid profile, blood pressure, body weight, blood vessel function and structure, deep venous thrombosis, coronary heart disease, primary versus secondary prevention, and cardiovascular disease risk factors such as family history, diet, obesity, smoking, unfavorable lipid profile, high homocysteine levels, high fibrinogen, low physical activity, diabetes and hypertension in addition to the menopause. Specific chapters cover pulsed estrogen therapy with Aerodiol and cardiovascular risk assessment in postmenopausal hormone replacement therapies such as Livial (tibolone). Includes bibliographic references and index. This volume is based on the formal presentations and subsequent discussions that took place at the InternationalMenopause Society specially convened Expert Workshop on Hormone Replacement Therapy and Cardiovascular Disease, London, UK, October 13-16, 2000.Andrea R. Genazzani is the author of 'Hormone Replacement Therapy and Cardiovascular Disease: The Current Status of Research and Practice', published 2001 under ISBN 9781842140383 and ISBN 1842140388.